In summary, our results showing frequent GPX3 inactivation by promoter hypermethylation in ccRCC may reveal the failure in the cellular antioxidant system, which is the first line of defense against detrimental ROS activity. The gene discussed is GPX3; the disease is nonpapillary renal cell carcinoma.